Agency Information Collection Activities, 25769-25770 [E8-10082]
Download as PDF
<![CDATA[
sroberts on PROD1PC70 with NOTICES
Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices
the matter can be obtained by contacting
the Commission’s TDD terminal on 202–
205–1810.
SUPPLEMENTARY INFORMATION: The
Commission instituted this investigation
on March 23, 2006, based on a
complaint filed by Epson Portland, Inc.
of Oregon; Epson America, Inc. of
California; and Seiko Epson Corporation
of Japan (collectively ‘‘Epson’’). 71 FR
14720 (March 23, 2006). The complaint,
as amended, alleged violations of
section 337 of the Tariff Act of 1930
(‘‘section 337’’) in the importation into
the United States, the sale for
importation, and the sale within the
United States after importation of
certain ink cartridges and components
thereof by reason of infringement of
claim 7 of U.S. Patent No. 5,615,957;
claims 18, 81, 93, 149, 164 and 165 of
U.S. Patent No. 5,622,439; claims 83 and
84 of U.S. Patent No. 5,158,377; claims
19 and 20 of U.S. Patent No. 5,221,148;
claims 29, 31, 34 and 38 of U.S. Patent
No. 5,156,472; claim 1 of U.S. Patent
No. 5,488,401; claims 1–3 and 9 of U.S.
Patent No. 6,502,917; claims 1, 31 and
34 of U.S. Patent No. 6,550,902; claims
1, 10 and 14 of U.S. Patent No.
6,955,422; claim 1 of U.S. Patent No.
7,008,053; and claims 21, 45, 53 and 54
of U.S. Patent No. 7,011,397. The
complaint further alleged that an
industry in the United States exists as
required by subsection (a)(2) of section
337. The complainants requested that
the Commission issue a general
exclusion order and cease and desist
orders. The Commission named as
respondents 24 companies located in
China, Germany, Hong Kong, Korea, and
the United States. Several respondents
were terminated from the investigation
on the basis of settlement agreements or
consent orders or were found in default.
On March 30, 2007, the presiding ALJ
(Judge Luckern) issued a final ID in the
investigation finding a violation of
section 337 with respect to certain
respondents. He found the asserted
claims valid and infringement by certain
respondents’ products. He
recommended issuance of a general
exclusion order and cease and desist
orders directed to certain respondents
and bond in the amount of $13.60 per
cartridge during the Presidential review
period.
On October, 19, 2007, after review,
the Commission made its final
determination in the investigation,
finding a violation of section 337. The
Commission issued a general exclusion
order, limited exclusion order, and
cease and desist orders directed to
several domestic respondents. The
Commission also determined that the
VerDate Aug<31>2005
21:00 May 06, 2008
Jkt 214001
public interest factors enumerated in 19
U.S.C. 1337(d), (f), and (g) did not
preclude issuance of the aforementioned
remedial orders, and that the bond
during the Presidential review period
would be $13.60 per cartridge for
covered ink cartridges.
On February 8, 2008, complainant
Epson filed two complaints seeking
enforcement proceedings under
Commission Rule 210.75. One
complaint alleges that Ninestar
Technology Co., Ltd.; Ninestar
Technology Company, Ltd.; and Town
Sky Inc. have violated the general
exclusion order and that Ninestar
Technology Company, Ltd. and Town
Sky Inc. have violated the cease and
desist orders directed to them. Epson’s
second complaint alleges that Mipo
International Ltd. and Mipo America,
Ltd. have violated the general and
limited exclusion orders and that Mipo
America, Ltd. has violated the cease and
desist order directed to it.
Having examined the complaints
seeking a formal enforcement
proceeding, and having found that the
complaints comply with the
requirements for institution of a formal
enforcement proceeding contained in
Commission rule 210.75, the
Commission has determined to institute
a consolidated formal enforcement
proceeding to determine whether the
five respondents are in violation of the
Commission’s exclusion orders and
cease and desist orders issued in the
investigation, and what, if any,
enforcement measures are appropriate.
The following entities are named as
parties to the formal enforcement
proceeding: (1) Complainant Epson, (2)
respondents (Ninestar Technology Co.,
Ltd.; Ninestar Technology Company,
Ltd.; Town Sky Inc.; Mipo America Ltd.,
and Mipo International, Ltd.) and (3) a
Commission investigative attorney to be
designated by the Director, Office of
Unfair Import Investigations.
The authority for the Commission’s
determination is contained in section
337 of the Tariff Act of 1930, as
amended (19 U.S.C. 1337), and in
section 210.75 of the Commission’s
Rules of Practice and Procedure (19 CFR
210.75).
Issued: May 1, 2008.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. E8–9984 Filed 5–6–08; 8:45 am]
BILLING CODE 7020–02–P
PO 00000
Frm 00129
Fmt 4703
Sfmt 4703
25769
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117–0010]
Agency Information Collection
Activities
30-day notice of information
collection under review.
ACTION:
Proposed collection; comments
requested:
U.S. Official Order Forms for Schedule
I and II Controlled Substances
(Accountable Forms), Order Form
Requisition—DEA Form 222 and 222a
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 73, Number 42, page
11443 on March 3, 2008, allowing for a
60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until June 6, 2008. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
E:\FR\FM\07MYN1.SGM
07MYN1
25770
Federal Register / Vol. 73, No. 89 / Wednesday, May 7, 2008 / Notices
Dated: May 2, 2008.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E8–10082 Filed 5–6–08; 8:45 am]
Overview of This Information
Collection
sroberts on PROD1PC70 with NOTICES
—Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Drug Enforcement Administration
21:00 May 06, 2008
Jkt 214001
DEPARTMENT OF JUSTICE
[OMB Number 1117–0021]
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection: U.S.
Official Order Forms for Schedule I and
II Controlled Substances (Accountable
Forms), Order Form Requisition (DEA
Form 222 and 222a).
(3) Agency form number, if any, and
the applicable component of the
Department sponsoring the collection:
Form number: DEA Form 222 and
222a.
Component: Office of Diversion
Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Not-for-profit, State, local or
tribal government.
Abstract: DEA–222 is used to transfer
or purchase Schedule I and II controlled
substances and data are needed to
provide an audit of transfer and
purchase. DEA–222a Requisition Form
is used to obtain the DEA–222 Order
Form. Persons may also digitally sign
and transmit orders for controlled
substances electronically, using a digital
certificate. Orders for Schedule I and II
controlled substances are archived and
transmitted to DEA.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 96,280
registrants submit forms annually for
this collection, taking an estimated
13.34 hours annually.
(6) An estimate of the total public
burden (in hours) associated with the
collection: DEA estimates that there will
be 1,283,935 annual burden hours
associated with the collection.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
VerDate Aug<31>2005
BILLING CODE 4410–09–P
Agency Information Collection
Activities: Proposed Collection;
Comments Requested
30-day notice of information
collection under review: Records and
Reports of Registrants.
ACTION:
The Department of Justice (DOJ), Drug
Enforcement Administration (DEA) will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. This
proposed information collection was
previously published in the Federal
Register Volume 73, Number 42, pages
11443–11444 on March 3, 2008,
allowing for a 60 day comment period.
The purpose of this notice is to allow
for an additional 30 days for public
comment until June 6, 2008. This
process is conducted in accordance with
5 CFR 1320.10.
Written comments and/or suggestions
regarding the items contained in this
notice, especially the estimated public
burden and associated response time,
should be directed to the Office of
Management and Budget, Office of
Information and Regulatory Affairs,
Attention Department of Justice Desk
Officer, Washington, DC 20503.
Additionally, comments may be
submitted to OMB via facsimile to (202)
395–5806.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
PO 00000
Frm 00130
Fmt 4703
Sfmt 4703
methodology and assumptions used;
Enhance the quality, utility, and clarity
of the information to be collected; and
—Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Records and Reports of Registrants.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection:
Form Number: None.
Office of Diversion Control, Drug
Enforcement Administration, United
States Department of Justice.
(4) Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Business or other for-profit.
Other: Not-for-profit institutions,
federal government, state, local or tribal
government.
Abstract: This information is needed
to maintain a closed system of
distribution by requiring the individual
practitioner to keep records of the
dispensing and administration of
controlled substances.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: DEA estimates that 103,000
respondents, with 103,000 responses
annually to this collection. DEA
estimates that it takes 30 minutes per
year for each practitioner to maintain
the necessary records.
(6) An estimate of the total public
burden (in hours) associated with the
collection: This information collection
creates an annual burden of 51,500
hours.
If additional information is required
contact: Lynn Bryant, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Patrick Henry Building,
Suite 1600, 601 D Street, NW.,
Washington, DC 20530.
Dated: May 2, 2008.
Lynn Bryant,
Department Clearance Officer, PRA, U.S.
Department of Justice.
[FR Doc. E8–10084 Filed 5–6–08; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 73, Number 89 (Wednesday, May 7, 2008)]
[Notices]
[Pages 25769-25770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-10082]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[OMB Number 1117-0010]
Agency Information Collection Activities
ACTION: 30-day notice of information collection under review.
-----------------------------------------------------------------------
Proposed collection; comments requested:
U.S. Official Order Forms for Schedule I and II Controlled Substances
(Accountable Forms), Order Form Requisition--DEA Form 222 and 222a
The Department of Justice (DOJ), Drug Enforcement Administration
(DEA) will be submitting the following information collection request
to the Office of Management and Budget (OMB) for review and approval in
accordance with the Paperwork Reduction Act of 1995. The proposed
information collection is published to obtain comments from the public
and affected agencies. This proposed information collection was
previously published in the Federal Register Volume 73, Number 42, page
11443 on March 3, 2008, allowing for a 60 day comment period.
The purpose of this notice is to allow for an additional 30 days
for public comment until June 6, 2008. This process is conducted in
accordance with 5 CFR 1320.10.
Written comments and/or suggestions regarding the items contained
in this notice, especially the estimated public burden and associated
response time, should be directed to the Office of Management and
Budget, Office of Information and Regulatory Affairs, Attention
Department of Justice Desk Officer, Washington, DC 20503. Additionally,
comments may be submitted to OMB via facsimile to (202) 395-5806.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address one or more of the following
four points:
--Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to
be collected; and
[[Page 25770]]
--Minimize the burden of the collection of information on those who
are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Overview of This Information Collection
(1) Type of Information Collection: Extension of a currently
approved collection.
(2) Title of the Form/Collection: U.S. Official Order Forms for
Schedule I and II Controlled Substances (Accountable Forms), Order Form
Requisition (DEA Form 222 and 222a).
(3) Agency form number, if any, and the applicable component of the
Department sponsoring the collection:
Form number: DEA Form 222 and 222a.
Component: Office of Diversion Control, Drug Enforcement
Administration, Department of Justice.
(4) Affected public who will be asked or required to respond, as
well as a brief abstract:
Primary: Business or other for-profit.
Other: Not-for-profit, State, local or tribal government.
Abstract: DEA-222 is used to transfer or purchase Schedule I and II
controlled substances and data are needed to provide an audit of
transfer and purchase. DEA-222a Requisition Form is used to obtain the
DEA-222 Order Form. Persons may also digitally sign and transmit orders
for controlled substances electronically, using a digital certificate.
Orders for Schedule I and II controlled substances are archived and
transmitted to DEA.
(5) An estimate of the total number of respondents and the amount
of time estimated for an average respondent to respond: DEA estimates
that 96,280 registrants submit forms annually for this collection,
taking an estimated 13.34 hours annually.
(6) An estimate of the total public burden (in hours) associated
with the collection: DEA estimates that there will be 1,283,935 annual
burden hours associated with the collection.
If additional information is required contact: Lynn Bryant,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Patrick Henry
Building, Suite 1600, 601 D Street, NW., Washington, DC 20530.
Dated: May 2, 2008.
Lynn Bryant,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. E8-10082 Filed 5-6-08; 8:45 am]
BILLING CODE 4410-09-P
